DARPP‐32 and Phosphatase Inhibitor‐1, Two Structurally Related Inhibitors of Protein Phosphatase‐1, Are Both Present in Striatonigral Neurons

Journal of Neurochemistry

Volumn 50, Issue 1, 1988, Pages 257-262

  Nairn, Angus C ^a   Hemmings, Hugh C ^a   Walaas, S Ivar ^a   Greengard, Paul ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Kainic acid; Neostriatum; Substantia nigra

Indexed keywords

KAINIC ACID; PHOSPHOPROTEIN; PHOSPHOPROTEIN DARPP 32; PHOSPHOPROTEIN PHOSPHATASE 1;

ANIMAL CELL; NEOSTRIATUM; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMAL; BASAL GANGLIA; COMPARATIVE STUDY; CORPUS STRIATUM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; KAINIC ACID; MALE; MUSCLES; NERVE TISSUE PROTEINS; NEURONS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEINS; RATS; RATS, INBRED STRAINS; SUBSTANTIA NIGRA; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023850124     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1988.tb13258.x     Document Type: Article

References (36)

1. Isolation and characterization of active fragments of protein phosphatase inhibitor‐1 from rabbit skeletal muscle
2. Complete primary structure of protein phosphatase inhibitor‐1 from rabbit skeletal muscle
3. A specific substrate from rabbit cerebellum for guanosine 3′:5′‐monophosphate‐dependent protein kinase
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding
5. The role of protein phosphorylation in neural and hormonal control of cellular activity
6. In situ injection of kainic acid: a new method for selectively lesioning neuronal cell bodies while sparing axons of passage
7. Localization in mammalian brain of G‐substrate, a specific substrate for guanosine 3′:5′‐cyclic monophosphate‐dependent protein kinase
8. The regulation of glycogen metabolism. Purification and properties of protein phosphatase inhibitor‐2 from rabbit skeletal muscle
9. The distribution of calcineurin in rat brain by light and electron microscopic immunocytochemistry and enzyme assay
10. DARPP‐32, a dopamine‐ and adenosine‐3′:5′‐monophosphate‐regulated phosphoprotein: regional, tissue and phylogenetic distribution
11. DARPP‐32, a dopamine‐regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase‐1
12. DARPP‐32, a dopamine and adenosine 3′:5′‐monophosphate‐regulated phosphoprotein enriched in dopamine‐innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus
13. DARPP‐32, a dopamine and adenosine 3′:5′‐monophosphate‐regulated phosphoprotein enriched in dopamine‐innervated brain regions. II. Comparison of the kinetics of phosphorylation of DARPP‐32 and phosphatase inhibitor 1
14. The protein phosphatases involved in cellular regulation. 1. Classification and substrate specificities
15. The protein phosphatases involved in cellular regulation. 6. Measurement of type‐1 and type‐2 protein phosphatases in extracts of mammalian tissues; an assessment of their physiological roles
16. v‐src
17. Microinjection of catalytic subunits of cyclic AMP‐dependent protein kinase enhances calcium action potentials of bag cell neurons in cell culture
18. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
19. Protein measurement with the Folin phenol reagent
20. Some factors influencing the neurotoxicity of intrastriatal injections of kainic acid
21. Protein kinases in the brain
22. The anatomy of the extrapyramidal system,
23. The regulation of glycogen metabolism. Purification and characterisation of protein phosphatase inhibitor‐1 from rabbit skeletal muscle
24. DARPP‐32, a dopamine and adenosine 3′:5′‐monophosphate‐regulated phosphoprotein enriched in dopamine‐innervated brain regions. III. Immunocytochemical localization
25. The internal organization of the neostriatum in mammals,
26. Striatal lesions with kainic acid: neurochemical characteristics
27. Adenosine 3′:5′‐monophosphate‐regulated phosphoprotein system of neuronal membranes. I. Solubilization, purification, and some properties of an endogenous phosphoprotein
28. The effects of kainic acid injections on guanylate cyclase activity in the rat caudatoputamen, nucleus accumbens and septum
29. DARPP‐32, a dopamine and adenosine 3′:5′‐monophosphate‐regulated phosphoprotein enriched in dopamine‐innervated brain regions
30. Phosphorylation of brain proteins,
31. A dopamine‐and cyclic AMP‐regulated phosphoprotein enriched in dopamine‐innervated brain regions
32. DARPP‐32: a dopamine‐regulated phosphoprotein in the basal ganglia,
33. Individual comparisons by ranking methods
34. DARPP‐32, a dopamine‐ and cyclic AMP‐regulated neuronal phosphoprotein. Primary structure and homology with protein phosphatase inhibitor‐1
35. 90) in basal ganglia of mouse brain